Department of Medicine, Center for Translational Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Department of Medicine, Center for Translational Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Neuroscience. 2023 Aug 21;526:204-222. doi: 10.1016/j.neuroscience.2023.06.019. Epub 2023 Jun 28.
Current data suggest a hypothesis of vascular pathogenesis for the development and progression of Alzheimer's disease (AD). To investigate this, we studied the association of apolipoprotein E4 (APOE4) gene on microvessels in human autopsy-confirmed AD with and without APOE4, compared with age/sex-matched control (AC) hippocampal CA1 stratum radiatum. AD arterioles (without APOE4 gene) had mild oxidative stress and loss of vascular endothelial growth factor (VEGF) and endothelial cell density, reflecting aging progression. In AD + APOE4, an increase in strong oxidative DNA damage marker 8-hydroxy-2'-deoxyguanosine (8-OHdG), VEGF, and endothelial cell density were associated with increased diameter of arterioles and perivascular space dilation. In cultured human brain microvascular cells (HBMECs), treatment of ApoE4 protein plus amyloid-β (Aβ) oligomers increased superoxide production and the apoptotic marker cleaved caspase 3, sustained hypoxia inducible factor-1α (HIF-1α) stability that was associated with an increase in MnSOD, VEGF, and cell density. This cell over-proliferation was inhibited with the antioxidants N-acetyl cysteine and MnTMPyP, the HIF-1α inhibitor echinomycin, the VEGFR-2 receptor blocker SU1498, the protein kinase C (PKC) ε knock-down (KD) and the extracellular signal-regulated kinase 1/2 (ERK) inhibitor FR180204. The PKCε KD and echinomycin decreased VEGF and/or ERK. In conclusion, AD capillaries and arterioles in hippocampal CA1 stratum radiatum of non-APOE4 carriers are related with aging, while those in APOE4 carriers with AD are related with pathogenesis of cerebrovascular disease.
目前的数据表明,血管发病机制假说可能与阿尔茨海默病(AD)的发生和发展有关。为了研究这一点,我们研究了载脂蛋白 E4(APOE4)基因在人类尸检证实的 AD 患者伴有和不伴有 APOE4 的微血管中的作用,与年龄/性别匹配的对照(AC)海马 CA1 放射层进行比较。AD 小动脉(不携带 APOE4 基因)存在轻度氧化应激和血管内皮生长因子(VEGF)和内皮细胞密度丧失,反映了衰老的进展。在 AD+APOE4 中,强氧化 DNA 损伤标志物 8-羟基-2'-脱氧鸟苷(8-OHdG)、VEGF 和内皮细胞密度的增加与小动脉直径的增加和血管周围空间扩张有关。在培养的人脑微血管细胞(HBMEC)中,ApoE4 蛋白加淀粉样β(Aβ)寡聚体的处理增加了超氧化物的产生和凋亡标志物 cleaved caspase 3,持续的缺氧诱导因子-1α(HIF-1α)稳定性与 MnSOD、VEGF 和细胞密度的增加有关。抗氧化剂 N-乙酰半胱氨酸和 MnTMPyP、HIF-1α 抑制剂 echinomycin、VEGFR-2 受体阻滞剂 SU1498、蛋白激酶 C(PKC)ε 敲低(KD)和细胞外信号调节激酶 1/2(ERK)抑制剂 FR180204 抑制了这种细胞过度增殖。PKCε KD 和 echinomycin 降低了 VEGF 和/或 ERK。总之,非 APOE4 携带者海马 CA1 放射层的 AD 毛细血管和小动脉与衰老有关,而 APOE4 携带者的 AD 与脑血管疾病的发病机制有关。